Publication date: March 2017
Source:Oral Oncology, Volume 66
Author(s): Valeria Mercadante, Arwa Al Hamad, Giovanni Lodi, Stephen Porter, Stefano Fedele
IntroductionSalivary gland hypofunction is a common and permanent adverse effect of radiotherapy to the head and neck. Randomised trials of available treatment modalities have produced unclear results and offer little reliable guidance for clinicians to inform evidence-based therapy. We have undertaken this systematic review and meta-analysis to estimate the effectiveness of available interventions for radiotherapy-induced xerostomia and hyposalivation.MethodsWe searched MEDLINE, Cochrane Central, EMBASE, AMED, and CINAHL database through July 2016 for randomised controlled trials comparing any topical or systemic intervention to active and/or non-active controls for the treatment of radiotherapy-induced xerostomia. The results of clinically and statistically homogenous studies were pooled and meta-analyzed.Results1732 patients from twenty studies were included in the systematic review. Interventions included systemic or topical pilocarpine, systemic cevimeline, saliva substitutes/mouthcare systems, hyperthermic humidification, acupuncture, acupuncture-like transcutaneous electrical nerve stimulation, low-level laser therapy and herbal medicine. Results from the meta-analysis, which included six studies, suggest that both cevimeline and pilocarpine can reduce xerostomia symptoms and increase salivary flow compared to placebo, although some aspects of the relevant effect size, duration of the benefit, and clinical meaningfulness remain unclear. With regard to interventions not included in the meta-analysis, we found no evidence, or very weak evidence, that they can reduce xerostomia symptoms or increase salivary flow in this population.ConclusionsPilocarpine and cevimeline should represent the first line of therapy in head and neck cancer survivors with radiotherapy-induced xerostomia and hyposalivation. The use of other treatment modalities cannot be supported on the basis of current evidence.
from #ORL via a.lsfakia on Inoreader http://ift.tt/2iRkfxu
via IFTTT
Alexandros G .Sfakianakis,ENT,Anapafeos 5 Agios Nikolaos Crete 72100 Greece,00302841026182
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Abstract Purpose of Review Heart failure is associated with an enormous burden on both patients and health care systems in the USA. Seve...
-
Ειδοποίηση Μελετητή:[ "κλιματική αλλαγή" ] [PDF] Ρομποτική στην αυτοκινητοβιομηχανία Γ Λιάσκος - 2017 Page 1. ΣΧΟΛΗ ΤΕΧΝΟΛΟΓΙΚΩΝ ...
-
Does CBD Oil Lower Blood Pressure? This article was originally published at SundayScaries." Madeline Taylor POSTED ON January 13, 20...
-
Πέμπτη, 22 Ιουνίου 2017 Treatment of Primary and Metastatic Multifocal Mucosal Melanoma of the Oral Cavity with Imatinib Treatment of Primar...
-
Ροές που μπορεί να σας αρέσουν Να μην εμφανιστεί αυτό ξανά Cardiovascular / Cardiology News From Medical News Today Latest Health News and M...
-
Oral Candida colonization in xerostomic post‐radiotherapy head and neck cancer patients 16h ... Oral Candida colonization in xerostomic post...
-
ONKO-Internetportal-Team Mammakarzinom: Molekulare Diagnostik und Erkenntnisse zum Lebensstil In einer Langzeitbeobachtung von der Geburt ...
-
Journal of visualized experiments : JoVE,http://www.jove.com/ Surface Electromyographic Biofeedback... Journal of visualized experiments : J...
-
Πέμπτη, 17 Οκτωβρίου 2019 Behavioral Sciences, Vol. 9, Pages 110: A Qualitative Study Examining the Illness Narrative Master... Behavioral S...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου